Treatment of Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy with N-Acetylcysteine Amide (NACA) or (2R,2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide)(DiNACA)

• 收藏
• 分享

专利权人:

Inc.;Nacuity Pharmaceuticals

发明人:

G. Michael Wall

申请号：

US16738819

公开号：

US20200222344A1

申请日:

2020.01.09

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention includes a method for the treatment of age-related macular degeneration, glaucoma, or diabetic retinopathy in a human that comprises administering to the human a therapeutically effective amount of N-acetylcysteine amide (NACA) or (2R,2R′；)-3,3′；-disulfanediyl bis(2-acetamidopropanamide) (diNACA) sufficient to treat or reduce the symptoms of the age-related macular degeneration, glaucoma, or diabetic retinopathy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/